Central Medical Stores Pharmaceutical Import Profile — Botswana (DGFT 2022–2026)

Name: Central Medical Stores Pharmaceutical Import Records from India — 2 Products, $300.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Central Medical Stores — Pharmaceutical Importer Profile (2026) | 2 Products, $300.0K Trade | TransData Nexus

Central Medical Stores

Pharmaceutical Importer · Botswana · Cardiovascular Focus · $300.0K Total Trade · DGFT Verified

Central Medical Stores is a pharmaceutical importer based in Botswana with a total trade value of $300.0K across 2 products in 1 therapeutic categories. Based on 6 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Central Medical Stores sources from 37 verified Indian suppliers, with Biological E. Limited accounting for 30.2% of imports.

Central Medical Stores — Import Portfolio & Supplier Network

Central Medical Stores import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Central Medical Stores?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Biological E. Limited	$4.9M	101	30.2%
Hester Biosciences Limited	$2.4M	82	14.7%
Panacea Biotec Limited	$1.9M	38	11.7%

What Formulations Does Central Medical Stores Import?

Formulation	Value	Ships
Typhoid conjugate vaccine monovalent 5 dose 2.5ML vial with vaccine vial monitor(vvm)	$1.1M	21
Dtp-hepb-hib (pentavalent vaccine)	$1.0M	20
Easy five tt vaccine dtwp-hepb-hib	$747.2K	15
[mixed vaccines for diphtheria and	$676.2K	15
Dtp-hepb-hib (pentavalent vaccine) dtp-hepb-hib (pentavalent vaccine) fully liquid combination vaccine,single	$600.0K	12
Mr vaccine measles and rubella vaccine	$550.0K	11
Diphtheria and tetanus (dt)/ tetanus	$450.0K	9
Mr vaccine measles and rubella vaccine combined vial of 5 doses with diluent. with vaccine vial monitor (vvm)	$400.0K	8
Easy five tt vaccine dtwp-hepb-hib pentavalent vaccine (Each vial of 0.5 ML contains 1 dose) with vaccine vial monitor	$400.0K	8
Nirmcom nirmatrel vir+ritona vir 150MG+100MG tablet 3s (18944 packs	$300.0K	6
Dtp-hepb-hib (pentavalent vaccine) fullyliquid combination vaccine,single dosevial(0.5ML) vial,pediatric dose	$250.0K	5
Easy five tt vaccine dtwp-hepb-hib pentavalent vaccine Each vial of 0.5 ML contains 1 dose easy five tt vaccine with	$200.0K	4
Easy five tt vaccine dtwp-hepb-hib pentavalent vaccine (Each vial of 0.5 ML contains 1 dose) with vaccine vial monitor	$200.0K	4
Easy five tt vaccine dtwp hepb hib pentavalent vaccine Each vial of 0 5 ML contains 1 dose with vaccine vial monitor	$200.0K	4
Paracetamol tablets BP 500MG	$185.6K	4

Central Medical Stores imports 1,144 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Enalapril	Cardiovascular	$150.0K	3	0.1%	13
2	Nifedipine	Cardiovascular	$150.0K	3	0.5%	9

Central Medical Stores imports 2 pharmaceutical products across 1 categories into Botswana totaling $300.0K.

Central Medical Stores — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Central Medical Stores (CMS) is a pharmaceutical importer and buyer based in Gaborone, Botswana. Operating as a government procurement entity, CMS plays a pivotal role in the country's healthcare system by sourcing and distributing essential medicines and medical supplies. This ensures that both public and private healthcare facilities have access to necessary pharmaceuticals. The organization is headquartered at Gaborone West Industrial Site Kgomoka 22/02/3/456, P.O.Box 639, Gaborone.

CMS's primary function is to procure and supply a wide range of pharmaceutical products to meet the healthcare needs of Botswana's population. By centralizing procurement, CMS aims to achieve cost efficiencies and maintain consistent quality standards across the nation's medical facilities. This centralized approach also facilitates better inventory management and distribution logistics, ensuring timely delivery of medicines to various healthcare providers.

2Distribution Network

While specific details about CMS's warehouse locations and logistics capabilities are not publicly disclosed, it is known that the organization operates within Botswana's established distribution infrastructure. This includes utilizing the country's main ports of entry and collaborating with local transportation networks to ensure efficient delivery of pharmaceutical products. Given Botswana's landlocked geography, CMS likely relies on regional trade routes, particularly through neighboring South Africa, to import medicines. This necessitates coordination with customs authorities and adherence to import regulations to facilitate smooth cross-border trade.

CMS's distribution network is designed to cover the entire country, ensuring that both urban and rural healthcare facilities receive the necessary medical supplies. The organization likely employs a combination of direct deliveries and partnerships with local distributors to reach various regions effectively. This comprehensive coverage is essential for maintaining the health and well-being of Botswana's population, especially in remote areas where access to medical supplies can be limited.

3Industry Role

In Botswana's pharmaceutical supply chain, Central Medical Stores serves as a primary wholesaler and government procurement entity. By centralizing the procurement and distribution of pharmaceutical products, CMS ensures that healthcare facilities across the country have access to essential medicines. This centralized approach allows for standardized quality control, cost efficiencies, and streamlined logistics, which are crucial for maintaining a consistent supply of pharmaceuticals.

CMS's role is particularly significant in a landlocked country like Botswana, where importing medicines involves navigating complex logistics and regulatory requirements. By managing these processes centrally, CMS can negotiate better terms with suppliers, ensure compliance with import regulations, and address any supply chain challenges more effectively. This strategic position enables CMS to play a critical role in the nation's healthcare system, ensuring that both public and private healthcare providers have access to the necessary pharmaceutical products.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Central Medical Stores

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Central Medical Stores's sourcing strategy exhibits a high degree of concentration, with a total import value of $300,000 USD from India across six shipments. The top two products imported are Enalapril and Nifedipine, each accounting for $150,000 USD, representing 0.1% and 0.5% of the total import value, respectively. Both products fall under the cardiovascular therapeutic category, indicating a focused approach to sourcing specific pharmaceutical formulations.

This concentrated sourcing strategy suggests that CMS may be leveraging strategic partnerships with Indian suppliers to secure favorable pricing and ensure a consistent supply of these critical medications. However, such dependency on a limited number of suppliers and products could pose risks, including potential supply disruptions or price fluctuations. To mitigate these risks, CMS may consider diversifying its supplier base and product portfolio, ensuring a more resilient and adaptable supply chain.

2Supply Chain Resilience

The resilience of Central Medical Stores's Indian supply chain is influenced by several factors, including the stability of supplier relationships, the diversity of imported formulations, and exposure to shipping route disruptions. With a total of 37 unique suppliers and 1,144 unique formulations imported, CMS demonstrates a relatively diverse sourcing strategy. This diversity can enhance supply chain resilience by reducing dependency on a single supplier or product.

Importing Pharmaceuticals into Botswana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Botswana

1Regulatory Authority & Framework

The Botswana Medicines Regulatory Authority (BoMRA) is the primary regulatory body responsible for overseeing the safety, efficacy, and quality of medicines and related substances in Botswana. Established under the Medicines and Related Substances Act (MRSA), BoMRA's key functions include product evaluation and registration, pharmacovigilance, clinical trials oversight, and import/export control. (bomra.co.bw)

The MRSA provides the legal framework for the importation, exportation, distribution, and sale of medicines in Botswana. According to the Act, no drug shall be imported into or exported from Botswana, or manufactured, distributed, or sold, unless such drug has been registered by the Director of Health Services.

2Import Licensing & GMP

Importers of pharmaceutical products into Botswana must obtain import licenses from BoMRA. The application process involves submitting the prescribed form, paying the required fee, and providing necessary information as specified by the authority. Importers must be residents of Botswana and operate under the continuous supervisory control of a pharmacist.

BoMRA recognizes Good Manufacturing Practice (GMP) certificates from reputable international regulatory bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their suppliers hold valid GMP certifications to comply with BoMRA's standards.

Central Medical Stores — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Central Medical Stores's focus on importing cardiovascular medications, specifically Enalapril and Nifedipine, aligns with the high prevalence of cardiovascular diseases in Botswana. This strategic choice is driven by the significant demand for these medications to manage conditions such as hypertension and heart failure. By prioritizing these products, CMS aims to address a critical health need and improve patient outcomes.

The decision to concentrate on cardiovascular drugs may also be influenced by cost considerations, as these medications are often available in generic forms, offering more affordable options. Additionally, the established efficacy and safety profiles of these drugs make them a reliable choice for treatment protocols.

2Sourcing Profile

CMS's sourcing strategy is centered on importing generic formulations from India, a country known for its robust pharmaceutical manufacturing sector. This approach allows CMS to access a wide range of cost-effective and quality-assured medications. By focusing on finished pharmaceutical formulations, CMS ensures that the products are ready for distribution and use, minimizing the need for additional processing or repackaging.

India's compliance with international quality standards, such as WHO GMP, further enhances the reliability of the imported products. This sourcing strategy supports CMS's objective of providing affordable and effective medications to the Botswana market.

Frequently Asked Questions — Central Medical Stores

What products does Central Medical Stores import from India?

Central Medical Stores imports 2 pharmaceutical products across 1 categories. Top imports: Enalapril ($150.0K), Nifedipine ($150.0K).

Who supplies pharmaceuticals to Central Medical Stores from India?

Central Medical Stores sources from 37 verified Indian suppliers. The primary supplier is Biological E. Limited (30.2% of imports, $4.9M).

What is Central Medical Stores's total pharmaceutical import value?

Central Medical Stores's total pharmaceutical import value from India is $300.0K, based on 6 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Central Medical Stores focus on?

Central Medical Stores imports across 1 categories. The largest: Cardiovascular (100.0%).

Get Full Central Medical Stores Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Central Medical Stores

Central Medical Stores — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Central Medical Stores?

What Formulations Does Central Medical Stores Import?

What Products Does Central Medical Stores Import?

Top Products by Import Value

Central Medical Stores Therapeutic Categories — 1 Specializations